Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies.
about
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewThe Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosisDoes Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate DiscussedUsing mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial.Moderated online social therapy for carers of young people recovering from first-episode psychosis: study protocol for a randomised controlled trialOptimizing psychosocial interventions in first-episode psychosis: current perspectives and future directionsArtificial Intelligence-Assisted Online Social Therapy for Youth Mental Health.Health beliefs and carer burden in first episode psychosis.Schizophrenia: an integrated sociodevelopmental-cognitive model.The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophreniaIntegrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial.Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse.The nature of relapse in schizophrenia.Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methodsHow much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library.Screening for substance use disorders in first-episode psychosis: implications for readmission.Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.The Effect of Paternal Age on Relapse in First-Episode Schizophrenia.Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled TrialPsychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study.Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorderImpact of universal health coverage on urban-rural inequity in psychiatric service utilisation for patients with first admission for psychosis: a 10-year nationwide population-based study in Taiwan.Potential Effects of the Choice of Costing Perspective on Cost Estimates: An Example Based on 6 Early Psychosis Intervention Programs.The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory studyThe revolving door of mental, neurological, and substance use disorders re-hospitalization in rural KwaZulu-Natal Province, South Africa.New Schizophrenia Treatments Address Unmet Clinical Needs.What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis.A review on schizophrenia and relapse--a quest for user-friendly psychopharmacotherapy.Relapse risk assessment in early phase psychosis: the search for a reliable and valid tool.Determinants of adherence to treatment in first-episode psychosis: a comprehensive review.Exploring compulsory admission experiences of adults with psychosis in the UK using Grounded Theory.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis."Worried about relapse": Family members' experiences and perspectives of relapse in first-episode psychosis.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.Perception towards relapse and its predictors in psychosis patients: A qualitative study.What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?Carers' and service users' experiences of early intervention in psychosis services: implications for care partnerships.
P2860
Q28079821-AB113C9D-19FF-4929-ABB2-165BFB72EE43Q28545094-AAB5C00B-269B-4188-B591-B1E63586B7C9Q30366949-60B1449F-2393-4CFB-9549-83706DBD4BD9Q33445067-27C6DE88-3AD9-4921-9FC0-8FEB911E5EA1Q33452296-75245B13-DCD9-458F-A1E6-F924BF700DC2Q33631663-A8B65109-E395-46F7-9766-38DCA484CAA7Q33753237-5989E849-D7B7-4D79-94B3-105EEB23C5FAQ33889742-B22D9CB4-171D-4518-9A44-AFD4AFC63D9DQ34023115-3CDD6031-47FF-438F-BFFD-216409559FB8Q34254832-FE92EF0D-A512-4866-8DEE-3F4E6AE70C0CQ34447011-7082D00C-AED5-4E01-830A-46FB62E0BB65Q34467748-13513DE8-3FF2-4B93-B1F8-096678A723ECQ34581127-B9E87F87-AA1E-4BC4-A1E6-1726ECB6CBB1Q34669624-0B345032-12DD-449B-AE27-6C2738E5DCE2Q35213673-B4F95598-007A-4EDA-8286-AED1A443A37AQ35323897-72AAD9D2-C24C-4B6A-92BB-BC9E1D3DA187Q35370011-93425FEF-2D9E-40C6-B21C-AB0EBB1D730AQ35605892-BBC43A72-1627-469F-AB63-224A8F4076F4Q35974134-AA514A95-1737-4E77-A24B-E05BAE8E3436Q35984960-97382892-043A-4FC5-B573-FC588871FA87Q36137208-C124963E-9CC4-4F1C-AA89-494D52066213Q36169820-D2DFEEAF-98D7-4CEA-A106-BEE30717ED92Q36406181-2DB09317-CC33-4C20-A4E5-7C6ECE408C0FQ36670517-1DC0DF69-DFFA-4340-9B11-38D43321D0FAQ37123399-352230F0-5DD2-4A5E-A49B-E0C61824B287Q37309552-6DB61D44-F3F9-43FF-927D-4B60E674CAC0Q37418388-C54A4A05-C570-4A88-81E7-6082A2C05AFBQ37605312-6DF704DC-2FB7-42EE-A563-1CE2F4799687Q38164122-23CED617-6B7E-4BAC-9EB4-6F522CED2434Q38233228-A6BF6C5C-486C-478B-835C-039E6C6D1AE9Q38363605-735DBA25-EA88-4BB6-98E9-88B016DD4EB1Q38462271-05AC6316-103D-48DA-AE30-09CB5E21BAE0Q38558881-093BCB15-70BD-44A6-A35F-16D864E75B54Q38570636-EC9BF122-F1F1-4F67-92C0-7B9A7149E559Q38680307-82E6AF05-87C9-40FE-93BB-603904C91637Q38681827-C94C9916-6552-458F-88AB-35FBBA32FC74Q38815462-BF80163C-CC21-4268-9AFC-5B42747630ACQ38826675-FADEBB2B-8E5A-44BD-B9A8-A77FC186A95CQ38867008-C463E3A4-8AF1-44D0-B931-C7B5719F54C5Q38921744-02676682-F0C7-44B2-9431-BC5F8780D3D4
P2860
Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors for relapse follo ...... lysis of longitudinal studies.
@en
type
label
Risk factors for relapse follo ...... lysis of longitudinal studies.
@en
prefLabel
Risk factors for relapse follo ...... lysis of longitudinal studies.
@en
P2093
P50
P1476
Risk factors for relapse follo ...... alysis of longitudinal studies
@en
P2093
A G Parker
E Killackey
P D McGorry
S E Hetrick
P304
P356
10.1016/J.SCHRES.2012.05.007
P407
P577
2012-06-01T00:00:00Z